Dr. Jeffrey Peppercorn has been appointed as the next Editor-in-Chief of JCO Oncology Practice (JCO OP), an American Society of Clinical Oncology (ASCO) journal. JCO OP publishes impactful information and insights to keep oncology practice current on changes and challenges inherent in delivering equitable, high-quality oncology care with an evolving value-based lens.
Dr. Peppercorn is a medical oncologist who specializes in breast cancer at Massachusetts General Hospital (MGH) Cancer Center in Boston, MA. His academic work involves both research and analysis of issues of health care delivery, access to care, cost, policy, and bioethics. Dr. Peppercorn served as Chair of the Ethics Committee of the Alliance for Clinical Trials in Oncology for over a decade and led the taskforce that founded the Value in Cancer Care Committee of the Alliance. While serving in multiple roles related to health services research within ASCO and the Alliance, he also participated in multiple Institute of Medicine panels on issues of cost and access to care.
Currently the inaugural Director of Supportive Care and Survivorship for the MGH Cancer Center, Dr. Peppercorn was also the founding Director of the Duke Cancer Institute Survivorship Program. In these roles, he has been engaged in both research and quality improvement initiatives. Dr. Peppercorn has been involved in international efforts to address cost of cancer care and participated in the ASCO Value taskforce that produced ASCO’s value framework. He has authored or co-authored over 150 papers.
Dr. Peppercorn will begin serving as Editor Designee of JCO OP on March 1, 2022, and as Editor-in-Chief on September 1.
Click here to read the original press release.
